Follow
José A. Muñoz-Moreno, Ph.D.
José A. Muñoz-Moreno, Ph.D.
Fundació Lluita contra la SIDA / Hospital Universitari Germans Trias i Pujol - Badalona, Barcelona, Catalonia
Verified email at flsida.org
Title
Cited by
Cited by
Year
Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program
Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ...
Clinical Infectious Diseases 56 (7), 1004-1017, 2013
2252013
Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence
CR Fumaz, JA Munoz-Moreno, J Moltó, E Negredo, MJ Ferrer, G Sirera, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 38 (5), 560-565, 2005
2072005
Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada
K Robertson, C Bayon, JM Molina, P McNamara, C Resch, ...
AIDS care 26 (12), 1555-1561, 2014
1422014
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients
JA Muñoz-Moreno, CR Fumaz, MJ Ferrer, A Prats, E Negredo, M Garolera, ...
AIDS research and human retroviruses 24 (10), 1301-1307, 2008
1402008
Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection
M Gonzalez-Garcia, MJ Ferrer, X Borras, JA Muñoz-Moreno, C Miranda, ...
AIDS and Behavior 18, 676-685, 2014
1102014
Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review
JA Munoz-Moreno, CR Fumaz, MJ Ferrer, M González-García, J Moltó, ...
Aids Rev 11 (2), 103-9, 2009
1042009
Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study
JA Muñoz-Moreno, CR Fumaz, MJ Ferrer, A Tuldrà, T Rovira, C Viladrich, ...
Aids Research and human retroviruses 23 (10), 1166-1175, 2007
862007
Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy
AM Anderson, JA Muñoz-Moreno, D McClernon, RJ Ellis, D Cookson, ...
The Journal of infectious diseases, jiw505, 2016
822016
Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach
E Negredo, J Moltó, JA Muñoz-Moreno, E Pedrol, E Ribera, P Viciana, ...
Antiviral therapy 9 (3), 335-342, 2004
622004
Resilience, ageing, and quality of life in long-term diagnosed HIV-infected patients
CR Fumaz, A Ayestaran, N Perez-Alvarez, JA Muñoz-Moreno, J Moltó, ...
Aids Care 27 (11), 1396-1403, 2015
612015
Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances
E Negredo, C Higueras, X Adell, JC Martinez, E Martinez, J Puig, ...
AIDS Patient Care & STDs 20 (12), 829-837, 2006
612006
Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment
CR Fumaz, M Gonzalez-Garcia, X Borras, JA Muñoz-Moreno, ...
Brain, behavior, and immunity 26 (4), 568-572, 2012
532012
Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs
CR Fumaz, JA Muñoz-Moreno, J Molto, MJ Ferrer, R López-Blázquez, ...
AIDS care 20 (7), 796-805, 2008
532008
A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen
JA Muñoz-Moreno, A Prats, N Pérez-Álvarez, CR Fumaz, M Garolera, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 63 (5), 585-592, 2013
462013
Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients
CR Fumaz, JA Munoz-Moreno, AL Ballesteros, R Paredes, MJ Ferrer, ...
AIDS care 19 (1), 138-145, 2007
402007
Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART
A Bonjoch, R Paredes, J Galvez, C Miralles, S Videla, E Martínez, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (3), 313-316, 2005
402005
Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy
E Negredo, J Puig, D Aldea, M Medina, C Estany, N Pérez-Álvarez, ...
AIDS research and human retroviruses 25 (4), 451-455, 2009
352009
Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints
M Ariza, N Cano, B Segura, A Adan, N Bargalló, X Caldú, A Campabadal, ...
Frontiers in aging neuroscience 14, 1029842, 2022
342022
Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study
JR Santos, JA Muñoz-Moreno, J Moltó, A Prats, A Curran, P Domingo, ...
PloS one 8 (7), e70201, 2013
322013
Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables
JA Muñoz-Moreno, N Pérez-Álvarez, A Muñoz-Murillo, A Prats, ...
PLoS One 9 (9), e107625, 2014
292014
The system can't perform the operation now. Try again later.
Articles 1–20